Know Cancer

or
forgot password

A Study of DTC in Patients With AIDS and AIDS Related Complex


N/A
18 Years
N/A
Not Enrolling
Both
HIV Infections

Thank you

Trial Information

A Study of DTC in Patients With AIDS and AIDS Related Complex

Inclusion Criteria


Inclusion Criteria

Concurrent Medication:

Allowed:

- Zidovudine (AZT).

Exclusion Criteria

Co-existing Condition:

Patients with the following are excluded:

- Active opportunistic infection or progressive Kaposi's sarcoma (KS).

- Dementia.

- Lymphoma.

Concurrent Medication:

Excluded within 3 weeks of study entry:

- Other experimental AIDS therapy.

Patients with the following are excluded:

- Active opportunistic infection or progressive Kaposi's sarcoma (KS).

Patients must be either HIV seropositive or have AIDS or AIDS related complex (ARC) and
have life expectancy of at least 6 months.

Type of Study:

Interventional

Study Design:

Primary Purpose: Treatment

Authority:

United States: Food and Drug Administration

Study ID:

010A

NCT ID:

NCT00002069

Start Date:

Completion Date:

Related Keywords:

  • HIV Infections
  • Ditiocarb
  • Acquired Immunodeficiency Syndrome
  • AIDS-Related Complex
  • Acquired Immunodeficiency Syndrome
  • HIV Infections
  • AIDS-Related Complex

Name

Location

San Francisco AIDS Clinic / San Francisco Gen HospSan Francisco, California  941102859
Duke Univ Med CtrDurham, North Carolina  27710
USC School of Medicine / Norris Cancer HospLos Angeles, California  90033
SUNY / Health Sciences Ctr at BrooklynBrooklyn, New York  112032098
Univ of Arizona / Arizona Cancer CtrTucson, Arizona  85724
Portion Med GroupSherman Oaks, California  91403
Florida Keys Memorial HospKey West, Florida  33040
Dr Gary BrewtonHouston, Texas  77027